Patents by Inventor Jurgen Karl Johannes Schwarze

Jurgen Karl Johannes Schwarze has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VACCINES USING NUCLEIC ACID-LIPID COMPLEXES
    Publication number: 20110002980
    Abstract: This invention relates to a vaccine and a method for immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from a disease including cancer, a disease associated with allergic inflammation, an infectious disease, or a condition associated with a deleterious activity of a self-antigen. Also disclosed are therapeutic compositions useful in such a method.
    Type: Application
    Filed: April 8, 2010
    Publication date: January 6, 2011
    Applicant: NATIONAL JEWISH MEDICAL AND RESEARCH CENTER
    Inventors: STEVEN W. DOW, ROBYN E. ELMSLIE, JURGEN KARL JOHANNES SCHWARZE, ERWIN W. GELFAND
  • Methods of using nucleic acid vector-lipid complexes
    Patent number: 7741300
    Abstract: This invention relates to a vaccine and a method for immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from a disease including cancer, a disease associated with allergic inflammation, an infectious disease, or a condition associated with a deleterious activity of a self-antigen. Also disclosed are therapeutic compositions useful in such a method.
    Type: Grant
    Filed: December 27, 2005
    Date of Patent: June 22, 2010
    Assignee: National Jewish Medical and Research Center
    Inventors: Steven W. Dow, Robyn E. Elmslie, Jurgen Karl Johannes Schwarze, Erwin W. Gelfand
  • VACCINES USING NUCLEIC ACID-LIPID COMPLEXES
    Publication number: 20090162427
    Abstract: This invention relates to a vaccine and a method for immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from a disease including cancer, a disease associated with allergic inflammation, an infectious disease, or a condition associated with a deleterious activity of a self-antigen. Also disclosed are therapeutic compositions useful in such a method.
    Type: Application
    Filed: March 6, 2009
    Publication date: June 25, 2009
    Applicant: NATIONAL JEWISH MEDICAL AND RESEARCH
    Inventors: Steven W. Dow, Robyn E. Elmslie, Jurgen Karl Johannes Schwarze, ERwin W. Gelfand
  • Systemic immune activation method using nucleic acid-lipid complexes
    Publication number: 20040157791
    Abstract: This invention relates to a method for systemic immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from a disease including cancer, a disease associated with allergic inflammation, or an infectious disease. Also disclosed are therapeutic compositions useful in such a method.
    Type: Application
    Filed: February 5, 2004
    Publication date: August 12, 2004
    Inventors: Steven W. Dow, Robyn E. Elmslie, Jurgen Karl Johannes Schwarze, Erwin W. Gelfand
  • Systemic immune activation method using nucleic acid-lipid complexes
    Patent number: 6693086
    Abstract: This invention relates to a method for systemic immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from a disease including cancer, a disease associated with allergic inflammation, or an infectious disease. Also disclosed are therapeutic compositions useful in such a method.
    Type: Grant
    Filed: June 25, 1998
    Date of Patent: February 17, 2004
    Assignee: National Jewish Medical and Research Center
    Inventors: Steven W. Dow, Robyn E. Elmslie, Jürgen Karl Johannes Schwarze
  • Vaccines using nucleic acid-lipid complexes
    Publication number: 20030022854
    Abstract: This invention relates to a vaccine and a method for immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from a disease including cancer, a disease associated with allergic inflammation, an infectious disease, or a condition associated with a deleterious activity of a self-antigen. Also disclosed are therapeutic compositions useful in such a method.
    Type: Application
    Filed: November 30, 2001
    Publication date: January 30, 2003
    Inventors: Steven W. Dow, Robyn E. Elmslie, Jurgen Karl Johannes Schwarze, Erwin W. Gelfand